Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | 1,2-dimethylhydrazine | affects expression | ISO | Evpl (Mus musculus) | 6480464 | 1 and 2-Dimethylhydrazine affects the expression of EVPL mRNA | CTD | PMID:22206623 | 1-chloro-2,4-dinitrobenzene | affects binding | ISO | EVPL (Homo sapiens) | 6480464 | Dinitrochlorobenzene binds to EVPL protein | CTD | PMID:32991956 | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | EVPL (Homo sapiens) | 6480464 | Tetrachlorodibenzodioxin results in increased expression of EVPL mRNA | CTD | PMID:20106945 and PMID:21632981 | 2,6-di-tert-butyl-4-methylphenol | increases expression | ISO | Evpl (Mus musculus) | 6480464 | Butylated Hydroxytoluene results in increased expression of EVPL mRNA | CTD | PMID:19925653 | 4,4'-sulfonyldiphenol | increases expression | ISO | Evpl (Mus musculus) | 6480464 | bisphenol S results in increased expression of EVPL mRNA | CTD | PMID:30951980 | 4,4'-sulfonyldiphenol | affects methylation | ISO | Evpl (Mus musculus) | 6480464 | bisphenol S affects the methylation of EVPL gene | CTD | PMID:31683443 | 4,4'-sulfonyldiphenol | increases methylation | ISO | Evpl (Mus musculus) | 6480464 | bisphenol S results in increased methylation of EVPL exon | CTD | PMID:33297965 | 6-propyl-2-thiouracil | decreases expression | EXP | | 6480464 | Propylthiouracil results in decreased expression of EVPL mRNA | CTD | PMID:24780913 | acrolein | multiple interactions | ISO | EVPL (Homo sapiens) | 6480464 | [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of EVPL mRNA and [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of EVPL mRNA | CTD | PMID:32699268 | aflatoxin B1 | increases expression | ISO | Evpl (Mus musculus) | 6480464 | Aflatoxin B1 results in increased expression of EVPL mRNA | CTD | PMID:19770486 | alpha-pinene | multiple interactions | ISO | EVPL (Homo sapiens) | 6480464 | [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of EVPL mRNA and [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of EVPL mRNA | CTD | PMID:32699268 | amitrole | decreases expression | EXP | | 6480464 | Amitrole results in decreased expression of EVPL mRNA | CTD | PMID:30047161 | aristolochic acid A | increases expression | ISO | EVPL (Homo sapiens) | 6480464 | aristolochic acid I results in increased expression of EVPL mRNA | CTD | PMID:33212167 | arsenite(3-) | multiple interactions | ISO | EVPL (Homo sapiens) | 6480464 | arsenite inhibits the reaction [G3BP1 protein binds to EVPL mRNA] | CTD | PMID:32406909 | arsenous acid | decreases response to substance | ISO | EVPL (Homo sapiens) | 6480464 | EVPL protein results in decreased susceptibility to Arsenic Trioxide | CTD | PMID:20707922 | atrazine | affects methylation | EXP | | 6480464 | Atrazine affects the methylation of EVPL gene | CTD | PMID:35440735 | benzo[a]pyrene | increases mutagenesis | ISO | EVPL (Homo sapiens) | 6480464 | Benzo(a)pyrene results in increased mutagenesis of EVPL gene | CTD | PMID:25435355 | benzo[a]pyrene | decreases methylation | ISO | EVPL (Homo sapiens) | 6480464 | Benzo(a)pyrene results in decreased methylation of EVPL promoter | CTD | PMID:27901495 | benzo[a]pyrene | increases methylation | ISO | EVPL (Homo sapiens) | 6480464 | Benzo(a)pyrene results in increased methylation of EVPL 3' UTR | CTD | PMID:27901495 | bisphenol A | decreases expression | ISO | EVPL (Homo sapiens) | 6480464 | bisphenol A results in decreased expression of EVPL mRNA | CTD | PMID:18007998 | bisphenol A | increases expression | ISO | Evpl (Mus musculus) | 6480464 | bisphenol A results in increased expression of EVPL mRNA | CTD | PMID:32156529 | bisphenol A | multiple interactions | ISO | EVPL (Homo sapiens) | 6480464 | [bisphenol A co-treated with Fulvestrant] results in decreased methylation of EVPL gene | CTD | PMID:31601247 | bisphenol A | decreases methylation | EXP | | 6480464 | bisphenol A results in decreased methylation of EVPL gene | CTD | PMID:28505145 | bisphenol A | decreases methylation | ISO | Evpl (Mus musculus) | 6480464 | bisphenol A results in decreased methylation of EVPL promoter | CTD | PMID:27312807 | bisphenol A | increases methylation | EXP | | 6480464 | bisphenol A results in increased methylation of EVPL gene | CTD | PMID:28505145 | bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of EVPL mRNA | CTD | PMID:25181051 and PMID:34947998 | bisphenol F | increases expression | ISO | Evpl (Mus musculus) | 6480464 | bisphenol F results in increased expression of EVPL mRNA | CTD | PMID:30951980 | bisphenol F | multiple interactions | ISO | EVPL (Homo sapiens) | 6480464 | [bisphenol F co-treated with Fulvestrant] results in decreased methylation of EVPL gene | CTD | PMID:31601247 | calcitriol | increases expression | ISO | EVPL (Homo sapiens) | 6480464 | Calcitriol results in increased expression of EVPL mRNA | CTD | PMID:26485663 | carbon nanotube | decreases expression | ISO | Evpl (Mus musculus) | 6480464 | Nanotubes and Carbon results in decreased expression of EVPL mRNA | CTD | PMID:25554681 | chlorpyrifos | increases expression | ISO | Evpl (Mus musculus) | 6480464 | Chlorpyrifos results in increased expression of EVPL mRNA | CTD | PMID:37019170 | choline | multiple interactions | ISO | Evpl (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of EVPL mRNA | CTD | PMID:20938992 | clobetasol | decreases expression | ISO | Evpl (Mus musculus) | 6480464 | Clobetasol results in decreased expression of EVPL mRNA | CTD | PMID:27462272 | diarsenic trioxide | decreases response to substance | ISO | EVPL (Homo sapiens) | 6480464 | EVPL protein results in decreased susceptibility to Arsenic Trioxide | CTD | PMID:20707922 | dichloroacetic acid | increases expression | ISO | Evpl (Mus musculus) | 6480464 | Dichloroacetic Acid results in increased expression of EVPL mRNA | CTD | PMID:28962523 | dicrotophos | increases expression | ISO | EVPL (Homo sapiens) | 6480464 | dicrotophos results in increased expression of EVPL mRNA | CTD | PMID:28302478 | diquat | increases expression | ISO | Evpl (Mus musculus) | 6480464 | Diquat results in increased expression of EVPL mRNA | CTD | PMID:36851058 | folic acid | multiple interactions | ISO | Evpl (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of EVPL mRNA | CTD | PMID:20938992 | fulvestrant | multiple interactions | ISO | EVPL (Homo sapiens) | 6480464 | [bisphenol A co-treated with Fulvestrant] results in decreased methylation of EVPL gene and [bisphenol F co-treated with Fulvestrant] results in decreased methylation of EVPL gene | CTD | PMID:31601247 | gentamycin | decreases expression | EXP | | 6480464 | Gentamicins results in decreased expression of EVPL mRNA | CTD | PMID:33387578 | L-methionine | multiple interactions | ISO | Evpl (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of EVPL mRNA | CTD | PMID:20938992 | lead(0) | decreases expression | ISO | EVPL (Homo sapiens) | 6480464 | Lead results in decreased expression of EVPL mRNA | CTD | PMID:19921347 | lipopolysaccharide | multiple interactions | ISO | EVPL (Homo sapiens) | 6480464 | [S-(1 and 2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in decreased expression of EVPL mRNA | CTD | PMID:35811015 | methimazole | decreases expression | EXP | | 6480464 | Methimazole results in decreased expression of EVPL mRNA | CTD | PMID:30047161 | methoxychlor | affects methylation | EXP | | 6480464 | Methoxychlor affects the methylation of EVPL gene | CTD | PMID:35440735 | ozone | multiple interactions | ISO | EVPL (Homo sapiens) | 6480464 | [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of EVPL mRNA more ... | CTD | PMID:32699268 | paracetamol | increases expression | EXP | | 6480464 | Acetaminophen results in increased expression of EVPL mRNA | CTD | PMID:33387578 | pirinixic acid | increases expression | ISO | Evpl (Mus musculus) | 6480464 | pirinixic acid results in increased expression of EVPL mRNA | CTD | PMID:23811191 | resveratrol | multiple interactions | ISO | EVPL (Homo sapiens) | 6480464 | [Plant Extracts co-treated with Resveratrol] results in decreased expression of EVPL mRNA | CTD | PMID:23557933 | S-(1,2-dichlorovinyl)-L-cysteine | multiple interactions | ISO | EVPL (Homo sapiens) | 6480464 | [S-(1 and 2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in decreased expression of EVPL mRNA | CTD | PMID:35811015 | sodium arsenite | increases expression | ISO | EVPL (Homo sapiens) | 6480464 | sodium arsenite results in increased expression of EVPL mRNA | CTD | PMID:34032870 | Theaflavin 3,3'-digallate | affects expression | ISO | EVPL (Homo sapiens) | 6480464 | theaflavin-3 and 3'-digallate affects the expression of EVPL mRNA | CTD | PMID:34925699 | thioacetamide | increases expression | EXP | | 6480464 | Thioacetamide results in increased expression of EVPL mRNA | CTD | PMID:34492290 | triptonide | increases expression | ISO | Evpl (Mus musculus) | 6480464 | triptonide results in increased expression of EVPL mRNA | CTD | PMID:33045310 | valproic acid | increases methylation | ISO | EVPL (Homo sapiens) | 6480464 | Valproic Acid results in increased methylation of EVPL gene | CTD | PMID:29154799 | | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
 |
Welcome {{ username}}
Message Center
{{ messageCount }} Messages
Watched Genes
{{$index + 1}}. {{ watchedObject.symbol }} (RGD ID:{{watchedObject.rgdId}})
Watched Ontology Terms
{{gene.symbol}}: {{ gene.description }}
|
| You must be logged in to use this feature |
| {{ loginError }} |
|
|
Analyze GeneStrainQTL List |
 Gene Annotator (Functional Annotation) unavailable |
 Gene Annotator (Annotation Distribution) unavailable |
 Variant Visualizer (Genomic Variants) unavailble Variant Visualizer (Genomic Variants) unavailable |
Gene Annotator (Functional Annotation) |
Gene Annotator (Annotation Distribution) |
Variant Visualizer (Genomic Variants) |
 InterViewer (Protein-Protein Interactions) unavailable |
 Gviewer (Genome Viewer) unavailable |
 Variant Visualizer (Damaging Variants) unavailble Variant Visualizer (Damaging Variants) unavailable |
InterViewer (Protein-Protein Interactions) |
GViewer (Genome Viewer) |
Variant Visualizer (Damaging Variants) |
 Gene Annotator (Annotation Comparison) unavailable |
 OLGA (Gene List Generator) unavailable |
 |
Gene Annotator (Annotation Comparison) |
OLGA (Gene List Generator) |
Excel (Download) |
 MOET (Multi-Ontology Enrichement) unavailable |
 GOLF (Gene-Ortholog Location Finder) unavailable |
|
MOET (Multi-Ontology Enrichement) |
GOLF (Gene-Ortholog Location Finder) |
|
||||||||||
Gene Ontology Annotations Click to see Annotation Detail View
Biological Process
Cellular Component
Molecular Function
